Chevidence

Multi-disciplinary research group promoting #evidence-based #medicine

[Chevidence @ChevidenceLab]

We are a multi-disciplinary research group based in the Evidence-Based Medicine (EBM) Center of #Lanzhou #University, #China. We promote using research evidence in healthcare practices and policies. #EBM #ResearchMatters #KNOWLEDGE

[Chevidence @ChevidenceLab]

Dr. Xuan Yu from the #Chevidence in collaboration with @harvardmed published a landmark series in Journal of the Royal Society of Medicine, reviewing the evolution of clinical trials in China from the 1940s until present.

[Chevidence @ChevidenceLab]

On June 10, 2025, the Excellence in Clinical Scientist Forum and Medical Research Literacy Training Series was hosted successfully by the First Hospital of Lanzhou University. Experts from @PKU1898 and @NTUsg shared their insights to boost clinical research capabilities.

[Chevidence @ChevidenceLab]

The Guidelines International Network (GIN) 2025 Conference @gin_member will be held in Geneva 16 to 19 September 2025. All 39 abstracts submitted by 19 members of Chevidence have been accepted (see the figure below)! Congratulations to all our team members!

[JAMA Network Open @JAMANetworkOpen]

A large language model assessed clinical practice guidelines with substantial consistency compared to human appraisers. https://t.co/57te029Imr

[Chevidence @ChevidenceLab]

The Dragon Boat Festival is here, igniting our passion and team spirit! The Chevidence team is ready to paddle through challenges and charge toward new goals this season. Stay tuned!

[Chevidence @ChevidenceLab]

We are so proud of our Chevidence team! Our 2 PhD and 3 Master's candidates have successfully defended their theses! Thank you for all these years of hard work—wishing you all a bright and brilliant future!

[Chevidence @ChevidenceLab]

Dr. Xufei Luo @Demon_Lux from the #Chevidence & the GAMER Working Group have just published the GAMER checklist in @BMJ_EBM. The checklist has 9 essential items that help to transparently report the use of #GenerativeAI in #medicalresearch.
https://t.co/Q6OJO5Aq8x

[Chevidence @ChevidenceLab]

On April 19-20, Prof. Yaolong Chen led #Chevidence to participate in the #ChinaMedicalDevelopmentConference. The conference focused on #artificialintelligence, exploring how to integrate algorithms, computing power & data to advance coordinated medical innovation.

[Chevidence @ChevidenceLab]

On 12 April 2025, the World Health Organization Guidelines Seminar was successfully held in Lanzhou by the #Chevidence team. Experts in medicine and computer science from China and abroad presented and discussed their work and viewpoints. #EvidenceBasedMedicine

[Chevidence @ChevidenceLab]

From April 8 to 9, 2025, Professor Yaolong Chen, Professor Janne Estill, Dr. Qianling Shi, and Dr. Yueyan Li from the Chevidence research group attended the @GRADE_WG #GRADEWorkingGroup meeting in Shanghai.

[Chevidence @ChevidenceLab]

March 22-26, 2025, our team led by Prof. Yaolong Chen attended the #AdvancingClinicalPathways and #PracticeGuidelines for #EvidenceBasedChineseMedicine & #IntegrativeMedicineSymposium at #HongKongBaptistUniversity@hkbaptistu. It was an honor to share our latest research findings!

[Chevidence @ChevidenceLab]

The Spring Equinox is a time for new beginnings, encouraging us to seize opportunities and work towards our goals! The Chevidence team is going to hold some big events in this spring. Looking forward!

[Chevidence @ChevidenceLab]

On January 15, 2025, the first paper in the STAR Guideline Terminology series, titled "STAR Guideline Terminology (I): Planning and Launching", was officially published in the Medical Journal of Peking Union Medical College Hospital.

[Chevidence @ChevidenceLab]

On this International Women's Day, our women scientists at Chevidence embraced traditional paper-cutting art, weaving medical precision into delicate designs while strengthening team bonds through creativity. Where beauty blooms at our fingertips—here's to every inspiring woman!

[Chevidence @ChevidenceLab]

On May 8th, "Enhancing the Transparency of Clinical Practice Guidelines by Prospective Registration: The PREPARE Platform" was published. The PREPARE platform is free for guideline developers worldwide. It supports submissions in both Chinese and English.

[Chevidence @ChevidenceLab]

Announcing the publication of the latest RIGHT-COI&F extension in the Annals of Internal Medicine. This crucial update provides comprehensive guidelines for the clear and transparent reporting of conflicts of interest and funding by guideline developers.#GuidelineDevelopment

[Chevidence @ChevidenceLab]

🌟 Prof. Song Fujian's Visit
On May 10, we welcomed Prof. Song from East Anglia to the Clinical Research Center, Lanzhou University. His talk at the Clinical Scientist Forum was inspiring. #Lanzhou #UEA

[Chevidence @ChevidenceLab]

On May 7th and 8th, 2024, members of the Chevidence project team traveled to Dunhuang for a team-building activity. This event was highly beneficial for everyone involved, deepening our understanding of each other and strengthening the team's cohesion.

[Chevidence @ChevidenceLab]

@EvidenceComm has published Update 2024. @lavisjn recommends you read the Report in Chinese, which was translated by the China Collaborating Center for the Global Evidence Commission and the Center for Evidence-Based Social Science, Lanzhou University https://t.co/sbDbUs4fq7

[Chevidence @ChevidenceLab]

《Global Evidence Commission update 2024》available in Chinese

[Global Commission on Evidence @EvidenceComm]

2024更新版报告现已提供中文版本| Update 2024 is now available in Chinese https://t.co/RzncSx8V3y